SCHEMBL24316416

SCHEMBL24316416

COc1cccc(CCOc2ncc(O)cc2OC)c1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.49
HTR1A P08908 4/20 0.47
DRD2 P14416 4/20 0.47
ABCB1 P08183 11/20 0.47
ALOX5 P09917 1/20 0.46
GABRA1 P14867 1/20 0.45
GABRG2 P18507 1/20 0.45
GABRB3 P28472 1/20 0.45
GABRA3 P34903 1/20 0.45
GABRA2 P47869 1/20 0.45
GABRB2 P47870 1/20 0.45
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24316412 0.87 CYP11B1 (0.48) DRD2ALOX5CYP11B1CYP11B2
SCHEMBL24316421 0.85 CALM1 (0.47) TAAR1CYP11B1CYP11B2
SCHEMBL24316417 0.77 TAAR1 (0.47) TAAR1ABCB1ALOX5
SCHEMBL24316419 0.76 PDGFRB (0.49) HTR1AMAOB
SCHEMBL21327653 0.75 CSF1R (0.54) MAOB
SCHEMBL24316986 0.74 KDM4E (0.50) HTR1AMAOB
SCHEMBL27717492 0.73 TAAR1 (0.61) TAAR1HTR1ADRD2ABCB1CHRM2
SCHEMBL30682056 0.71 CSF1R (0.42) TAAR1
SCHEMBL27968568 0.71 GABRA1 (0.81) TAAR1HTR1ADRD2ABCB1GABRA1
SCHEMBL29079537 0.71 AKR1B1 (0.62) TAAR1HTR1ADRD2ABCB1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022057895-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2022-03-24 WO disclosed
US-9585884-B2 Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 AUSPEX PHARMACEUTICALS, INC. (US) 2017-03-07 US disclosed